Literature DB >> 20861777

Performance of multidetector computed tomographic angiography in determining surgical resectability of pancreatic head adenocarcinoma.

Osamu F Kaneko1, Deborah M Lee, Jimmie Wong, Barbara M Kadell, Howard A Reber, David S K Lu, Steven S Raman.   

Abstract

OBJECTIVE: To evaluate the performance of multidetector computed tomographic angiography (MDCTA) in assessing the surgical resectability of pancreatic head adenocarcinoma.
METHODS: With institutional review board approval, radiographic, surgical, and pathological records of 203 consecutive patients with adenocarcinoma of the pancreatic head were analyzed retrospectively. Patients were imaged with MDCT scanners using our institution's CTA pancreatic protocol. Images were compared with surgical outcomes to determine the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of MDCTA in determining resectability.
RESULTS: Data were analyzed twice, once with equivocal findings on MDCTA assumed as resectable and again with equivocal cases assumed as unresectable. All equivocal cases were ultimately unresectable; when this was assumed, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were determined to be 100%, 71%, 85%,100% and 89%. Twelve patients deemed resectable by preoperative MDCTA were found to be unresectable on surgical exploration owing to vascular involvement (n = 4), liver metastases (n = 4), and peritoneal involvement (n = 4).
CONCLUSIONS: Multidetector CT angiography offers accurate and valuable preoperative assessment of surgical resectability of pancreatic ductal adenocarcinoma. Liver and peritoneal metastases and vascular invasion still remain important pitfalls in preoperative evaluation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861777     DOI: 10.1097/RCT.0b013e3181e5d6f7

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  9 in total

Review 1.  Diagnostic evaluation of solid pancreatic masses.

Authors:  Jeffrey L Tokar; Rohit Walia
Journal:  Curr Gastroenterol Rep       Date:  2013-10

2.  Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.

Authors:  Hop S Tran Cao; Alpana Balachandran; Huamin Wang; Graciela M Nogueras-González; Christina E Bailey; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans; Gauri Varadhachary; Christopher H Crane; Thomas A Aloia; Jean-Nicolas Vauthey; Jason B Fleming; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

3.  Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer.

Authors:  Jian Zhang; Chang-Jing Zuo; Ning-Yang Jia; Jian-Hua Wang; Sheng-Ping Hu; Zhong-Fei Yu; Yuan Zheng; An-Yu Zhang; Xiao-Yuan Feng
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

Review 4.  Surveillance for neoplasia in the pancreas.

Authors:  Kasper A Overbeek; Djuna L Cahen; Marcia Irene Canto; Marco J Bruno
Journal:  Best Pract Res Clin Gastroenterol       Date:  2016-11-05       Impact factor: 3.043

5.  Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.

Authors:  Paul F Laeseke; Ru Chen; R Brooke Jeffrey; Teresa A Brentnall; Jürgen K Willmann
Journal:  Radiology       Date:  2015-12       Impact factor: 11.105

Review 6.  Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature.

Authors:  Shailesh V Shrikhande; Savio George Barreto; Mahesh Goel; Supreeta Arya
Journal:  HPB (Oxford)       Date:  2012-06-14       Impact factor: 3.647

7.  Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT.

Authors:  Inne Somers; Shandra Bipat
Journal:  Eur Radiol       Date:  2017-01-16       Impact factor: 5.315

Review 8.  Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma.

Authors:  Geeta G Sharma; Yasuyuki Okada; Daniel Von Hoff; Ajay Goel
Journal:  Semin Cancer Biol       Date:  2020-10-10       Impact factor: 17.012

9.  The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: EUS oriented.

Authors:  Sevastiţa Iordache; Dana-Maria Albulescu; Adrian Săftoiu
Journal:  Endosc Ultrasound       Date:  2017-12       Impact factor: 5.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.